The Sulfotransferase Lottery: Why Minoxidil Works Great for Some, Not Others
Affiliate disclosure: This page contains affiliate links. We may earn a commission at no extra cost to you. Editorial content is independent.
Minoxidil response is partly a genetic lottery. The SULT1A1 enzyme activity you inherited determines how much active drug your follicles produce — and no product or technique changes that enzyme.
The phrase “minoxidil doesn't work for me” is heard frequently in hair loss communities. In most of those cases, the statement is biologically accurate — but the reason is not poor product quality, wrong application technique, or inadequate dose. It is genetics.
The SULT1A1 genetic variation
SULT1A1 — the sulfotransferase enzyme that converts minoxidil to its active metabolite — shows significant variation in activity between individuals based on inherited polymorphisms in the SULT1A1 gene. These polymorphisms affect how much functional enzyme is expressed in follicle outer root sheath cells. High-activity individuals convert minoxidil to minoxidil sulfate efficiently; low-activity individuals convert it poorly.
Research has estimated that approximately 70% of men have adequate SULT1A1 activity to respond to topical minoxidil; approximately 30% have activity low enough that the prodrug conversion is insufficient for a meaningful clinical response.
What this looks like clinically
Two men with the same AGA pattern, same minoxidil product, same twice-daily regimen, same duration of treatment can have dramatically different outcomes purely due to enzyme activity. The high-activity man sees meaningful density improvement at six months; the low-activity man sees minimal response despite identical protocol adherence. Neither is doing anything wrong.
The test option
SULT1A1 activity testing is available commercially and can predict minoxidil response before committing months to a trial. A blood draw or cheek swab is analysed for SULT1A1 gene variants and enzyme activity. High-activity result: minoxidil is likely to produce a good response. Low-activity result: oral minoxidil, combination with tretinoin (which may enhance conversion), or alternative treatments should be prioritised.
Strategies for suspected low converters
- Try oral minoxidil: Different pharmacokinetic profile; some topical non-responders respond to oral
- Add tretinoin to topical: Tretinoin increases SULT1A1 expression in skin and may enhance minoxidil conversion (this is the mechanism behind compounded minoxidil-tretinoin combinations)
- Consider finasteride-first or finasteride-primary: DHT-based approach unaffected by SULT1A1 activity
- SULT1A1 testing: Provides individual data before investing months in the trial
The lottery framing is not fatalistic. It is informational: knowing which category you are in allows a rational treatment decision rather than months of adhering to a protocol that the underlying genetics make unlikely to produce results.
Common questions
What percentage of people respond to minoxidil?
Clinical trials show approximately 60–70% of users see meaningful hair growth with topical minoxidil at 12 months. The remaining 30–40% see primarily stabilisation or minimal response. The underlying driver of this variation is believed to be largely genetic — specifically SULT1A1 enzyme activity variation.
Can I find out if I am a good minoxidil responder before starting?
SULT1A1 activity can be measured from a blood or cheek swab sample. Some commercial testing services offer this specifically for predicting minoxidil response. The test is not part of standard clinical practice but is available. Alternatively, a three-to-four month trial is still the most common approach to establishing individual response.
If I am a non-responder to topical minoxidil, will oral work?
Sometimes. Oral minoxidil provides systemic delivery that may overcome some topical absorption limitations. However, if the underlying issue is very low SULT1A1 activity at the follicle level, oral delivery may not fully resolve the non-response. Oral minoxidil is worth trying in topical non-responders; the response rate from oral is not uniformly better but some topical non-responders do respond to oral.
Get your prescription
Care Bare Rx
Telehealth hair consultations with licensed providers. Compounded minoxidil formulas — topical and oral — prescribed and shipped to your door after an online evaluation.
Start Your Care Bare Rx Intake Paid linkSesame Care
Book directly with licensed physicians at transparent upfront prices. FDA-approved minoxidil prescriptions (oral and topical), no membership fee, no insurance required.
Browse Sesame Care Providers Paid linkAbout compounded medications: Compounded drugs are prepared by a pharmacy for an individual patient and are not FDA-approved. The FDA does not review them for safety, effectiveness, or manufacturing quality. Discuss with a licensed prescriber before starting.
Affiliate Disclosure: This site earns commissions on referrals at no extra cost to you. Editorial content is independent.
Medical disclaimer: This article is for general information only and does not constitute medical advice, diagnosis, or treatment. Minoxidil is an FDA-approved medication with documented side effects. Always consult a licensed physician before starting, stopping, or changing any medication.